Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin plus calcium in second trimester to prevent superimposed preeclampsia in chronic hypertension
TCTR20170629006Phase 4Not yet recruiting
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, calcium in hypertension (HTN), preeclampsia, sponsored by NONE. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
aspirincalcium
03
Conditions
hypertension (HTN)preeclampsia
Beyond the preview
Go deeper on TCTR20170629006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170629006.